Medicines Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Medicines Co.

Medicines Co. | Ownership

Companies that own Medicines Co.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Fidelity Management & Research Co.

10,813,090

14.65%

-110,936

0.04%

06/30/2018

Wellington Management Co. LLP

10,284,536

13.94%

39,364

0.08%

06/30/2018

BlackRock Fund Advisors

9,622,866

13.04%

518,664

0.02%

06/30/2018

The Vanguard Group, Inc.

6,376,721

8.64%

228,871

0.01%

06/30/2018

Tavistock Life Sciences Co. (Investment Management)

5,028,742

6.82%

405,345

13.66%

06/30/2018

PointState Capital LP

4,012,490

5.44%

306,343

1.86%

06/30/2018

Westfield Capital Management Co. LP

3,281,183

4.45%

251,572

0.91%

06/30/2018

Bridger Management LLC

2,604,965

3.53%

-52,521

4.92%

06/30/2018

Putnam Investment Management LLC

2,251,231

3.05%

-268,913

0.17%

06/30/2018

Partner Fund Management LP

2,119,690

2.87%

-118,621

1.46%

06/30/2018

About Medicines

View Profile

Address	8 Sylvan Way Parsippany New Jersey 07054 United States
Employees	-
Website	http://www.themedicinescompany.com
Updated	07/08/2019
The Medicines Co. operates as a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A.